Static Chart Provectus Biopharmaceuticals, Inc.

Stocks

Real-time OTC Markets 15:37:28 2026-06-02 EDT			5-day change	1st Jan Change
0.0620 ^USD	-7.32%		+24.25%	+10.91%

08-13	Provectus Biopharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-07	Provectus Biopharmaceuticals, Inc. Highlights Peer-Reviewed Study Demonstrating Opposing Mechanistic Effects Of Rose Bengal Sodium At The Same Dose	CI

Duration

Period